Skip to content
The global nonprofit partnership CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is focused on supporting antibacterial research. Last week, CARB-X opened a call for […]
CARB-X’s call for proposals seeks to fill gaps in the global AMR pipeline Read More »
“Cancer’s resistance to treatments is the biggest challenge faced today in oncology, and this resistance is the cause of death from the disease,” said
OncoXome is charging ahead with gene therapy to treat resistant cancers Read More »
In the “first in a series of projects Shell is considering at its chemicals facilities along the Gulf Coast to accelerate the transition from
Shell plans to turn oil refinery into biorefinery producing SAFs Read More »
U.S. investment in sensitive, cutting-edge research abroad would be more tightly controlled under the proposed National Critical Capabilities Defense Act. The bipartisan legislation would
Bill would limit U.S. investment in foreign research Read More »
The United States government is under increased pressure from U.S. farmers to challenge Mexico’s impending ban on genetically modified corn that could “cost the
U.S. must challenge Mexico’s GM corn ban, say farmers and biotech industry Read More »
After making the misguided decision to waive intellectual property (IP) protections for COVID vaccines, the World Trade Organization (WTO) is thinking about extending the
BIO: Expanding COVID IP waiver could harm US biotech companies Read More »
Top White House officials engaged with leaders in the biotech industry yesterday in a summit covering the future of biotech and details of the
Administration and biotech industry leaders meet at White House biomanufacturing summit Read More »
US President Joe Biden signed an executive order on Monday that will “help expand U.S. biomanufacturing and reduce reliance on China,” according to Bloomberg.
Biomanufacturing to get a boost from Biden’s new executive order Read More »
The recently passed Inflation Reduction Act (IRA), which allocates $369 billion to ensuring energy security and halting climate change, is now being implemented by
BIO: IRA climate investment needs more biotech to meet goals Read More »
It’s an exciting time for research into microbiome therapeutics. This can be seen in the explosion of new clinical studies in the field, which,
A gut check on microbiome therapeutics development Read More »
